Skip to content

Privacy-first and secure. Your health information is always private and protected.

← Back to Journal

Mold and Toxins

Comprehensive guide to mold illness (CIRS), mycotoxins, heavy metals, and environmental toxin testing — plus evidence-based detox pathways and recovery strategies from a functional medicine perspective.

Key Takeaways

  • 1CIRS is a clinically defined, multi-system inflammatory illness triggered by biotoxin exposure in genetically susceptible individuals (24% of the population with HLA-DR variations) — it is not simply a mold allergy and requires specific biomarker testing for diagnosis.
  • 2The body detoxifies environmental toxins through sequential Phase I (cytochrome P450 activation) and Phase II (conjugation) liver pathways, with glutathione serving as the master antioxidant for both mycotoxin and heavy metal elimination.
  • 3Mercury from dental amalgam fillings is the predominant source of mercury in the adult central nervous system in developed countries, and subclinical effects on kidneys, immune function, and the CNS have been documented at exposure levels seen in amalgam bearers.
  • 4Effective treatment follows a strict sequence — source removal first, then toxin binding (cholestyramine, charcoal, clay), detoxification pathway support (glutathione, NAC, cruciferous vegetables), and finally tissue repair and immune restoration.
  • 5Recovery from environmental toxin illness requires patience and monitoring — in HLA-DR-susceptible individuals, mycotoxin half-lives can exceed 300 days, meaning full clearance may take years even after exposure ends.

Environmental toxins are no longer a fringe concern. From the mold colonizing water-damaged buildings to the mercury vapor released by dental amalgams, we are exposed to a persistent, low-grade toxic burden that modern medicine is only beginning to take seriously. The World Health Organization estimates that dampness and mold affect 10–50% of indoor environments in Europe, North America, and Australia[1] — and a growing body of research links these exposures to chronic, multi-system illness that can persist for years after initial contact.

This guide covers the science behind mold illness, heavy metal toxicity, and environmental chemical exposure — and maps the functional medicine approach to testing, detoxification, and recovery.

What Are Environmental Toxins?

Environmental toxins are substances produced by biological organisms or released through human industrial activity that can cause harm at low-level, chronic exposures. In functional medicine, the three most clinically relevant categories are:

  • Mycotoxins — toxic secondary metabolites produced by mold species such as Aspergillus, Stachybotrys (black mold), Penicillium, and Fusarium. These include aflatoxins, ochratoxin A, trichothecenes, and gliotoxin.
  • Heavy metals — mercury, lead, arsenic, cadmium, and aluminum, which accumulate in tissues over time from dietary, occupational, dental, and environmental sources.
  • Volatile organic compounds (VOCs) and endocrine disruptors — pesticides, phthalates, bisphenol A (BPA), and formaldehyde found in food packaging, building materials, and personal care products.

What makes these toxins particularly dangerous is not acute poisoning — it is the slow, cumulative burden they place on the immune system, liver detoxification pathways, and neurological function over months to decades.

The concept of "total toxic burden" is central to functional medicine's approach to environmental illness. Any single exposure — a modest mold colony in a bathroom, a few amalgam fillings, trace arsenic in drinking water — might fall within regulatory limits. But when these exposures stack, they overwhelm the body's finite detoxification capacity. The liver's Phase I and Phase II enzyme systems, the kidneys' filtration ability, and the antioxidant reserves (particularly glutathione) can become saturated, allowing toxins to accumulate in fat tissue, bone, and the central nervous system. This cumulative model explains why two people living in the same water-damaged building can have radically different outcomes — one recovers quickly upon leaving, while the other develops a chronic, debilitating illness.

Mold Illness and CIRS: The Biotoxin Pathway

Chronic Inflammatory Response Syndrome (CIRS) is the clinical term for a multi-system inflammatory illness triggered by exposure to biotoxins — most commonly from water-damaged buildings (WDBs). First characterized by Dr. Ritchie Shoemaker, CIRS involves a specific chain of immune dysregulation that distinguishes it from simple mold allergy[2].

The biotoxin pathway works like this: when a genetically susceptible person inhales mycotoxins, their immune system cannot properly tag and clear the toxin through normal antigen-presentation pathways. Instead, the biotoxin recirculates, triggering persistent innate immune activation — a state of chronic inflammation that does not resolve even after the person leaves the moldy environment.

The Role of HLA-DR Genetics

Approximately 24% of the population carries specific HLA-DR gene variations that impair their ability to clear biotoxins[3]. In these individuals, mycotoxin elimination is dramatically slowed. A 2024 case-report study published in Mycotoxin Research measured urinary mycotoxin levels in HLA-DR-susceptible individuals and found that ochratoxin A had an estimated half-life of approximately 311 days — roughly 10 times slower than expected in individuals without these alleles[3]. This means that even after moving out of a mold-contaminated home, susceptible individuals can remain symptomatic for years as toxins slowly clear.

Common Symptoms of Mold Illness

CIRS symptoms are notoriously broad, which is why mold illness is frequently misdiagnosed as fibromyalgia, depression, or chronic fatigue syndrome. The most commonly reported symptoms include:

  • Persistent fatigue and post-exertional malaise
  • Cognitive dysfunction — difficulty concentrating, word-finding problems, and brain fog
  • Joint and muscle pain without structural cause
  • Sinus congestion and chronic respiratory issues
  • Light sensitivity and night vision problems
  • Numbness, tingling, and temperature dysregulation
  • Gastrointestinal symptoms — bloating, abdominal pain, diarrhea
  • Mood disturbances — anxiety, irritability, depression

Mycotoxins can cause inflammation and oxidative stress throughout the body, and the resulting symptom profile overlaps heavily with Mast Cell Activation Syndrome (MCAS) and chronic Lyme disease[4]. The key differentiator is a history of water-damaged building exposure combined with biomarker abnormalities — not symptom presentation alone.

Can Mold Trigger Autoimmunity?

Emerging evidence suggests that chronic mold exposure may contribute to autoimmune disease development. The persistent innate immune activation seen in CIRS can dysregulate adaptive immune responses, potentially triggering molecular mimicry — where the immune system begins attacking the body's own tissues. This connection is an active area of research and a key reason why early detection and treatment of mold illness matters.

Heavy Metals: Mercury, Lead, and Arsenic

Heavy metal exposure is ubiquitous in modern life. Lead persists in older paint and water infrastructure. Arsenic contaminates groundwater and rice. And mercury — the most neurotoxic non-radioactive element — enters the body through two primary routes: dietary methylmercury from fish consumption and elemental mercury vapor from dental amalgam fillings.

Mercury Amalgam Fillings

Dental amalgam fillings are approximately 50% mercury by weight and continuously release low levels of mercury vapor, which is absorbed through the lungs and distributed to organs including the brain and kidneys. A comprehensive risk analysis published in Neurotoxicology concluded that mercury vapor from dental amalgam is the predominant source of mercury in the central nervous system of adults in developed countries[5]. Subclinical effects on kidneys, the immune system, thyroid function, and CNS function have been observed at exposure levels within the upper range seen in amalgam bearers.

Individual susceptibility varies considerably based on genetic polymorphisms affecting mercury metabolism — particularly variations in glutathione S-transferase (GST) and metallothionein genes. For a deeper look at the evidence, see our full article on mercury amalgam fillings and health risks.

Lead and Arsenic

Lead exposure, even at levels once considered safe, is now associated with cognitive decline, cardiovascular disease, and kidney damage. No safe blood lead level has been established in children. Arsenic, a known carcinogen, is found in groundwater, rice, and apple juice, and chronic low-level exposure has been linked to skin, lung, and bladder cancers as well as cardiovascular and metabolic effects.

Heavy metals exert toxicity primarily through three mechanisms: oxidative stress generation, displacement of essential minerals (zinc, selenium, magnesium) from enzyme binding sites, and direct disruption of protein structure[6]. These mechanisms are insidious because they operate below the threshold of acute symptoms — patients rarely connect their gradual cognitive decline, unexplained fatigue, or worsening anxiety to a toxic exposure that may have started years or even decades earlier.

Chelation — the process of binding metals with organic molecules for excretion — is the body's natural detoxification strategy for heavy metals. Glutathione and metallothionein are the primary endogenous chelators, forming complexes with both essential and toxic elements as they are sequestered, transported, and excreted[6]. When these systems are overwhelmed or genetically underperforming, pharmaceutical chelation agents (DMSA, DMPS, EDTA) may be considered under medical supervision to accelerate metal clearance.

Testing for Environmental Toxins

Accurate testing is the foundation of any toxin-related treatment plan. Functional medicine practitioners typically use a combination of the following approaches, detailed in our environmental toxin blood test guide:

Mycotoxin Testing

  • Urinary mycotoxin panels — tests like the RealTime Laboratories or Great Plains (Mosaic) GPL-MycoTOX profile detect specific mycotoxins (ochratoxin A, aflatoxins, gliotoxin, trichothecenes) in urine. Provocative glutathione challenges before collection may improve sensitivity.
  • Environmental testing — ERMI (Environmental Relative Moldiness Index) scoring uses dust samples to quantify mold DNA in the home or workplace.

Heavy Metal Testing

  • Blood metals panel — measures current circulating levels of mercury, lead, arsenic, and cadmium. Best for acute or recent exposure.
  • Provoked urine challenge — a chelation agent (DMSA, DMPS, or EDTA) is administered before collection to mobilize stored metals from tissues, providing a better picture of total body burden.
  • Hair mineral analysis — a non-invasive screening tool that reflects longer-term exposure but has limitations in accuracy.

CIRS-Specific Biomarkers

  • TGF-beta 1 — elevated in systemic inflammation and tissue remodeling
  • C4a — complement activation marker commonly elevated in CIRS
  • MMP-9 — matrix metalloproteinase indicating vascular inflammation
  • MSH (Melanocyte Stimulating Hormone) — typically suppressed in CIRS, leading to immune and hormonal dysregulation
  • VIP (Vasoactive Intestinal Peptide) — often low, contributing to respiratory and GI symptoms
  • VEGF — vascular endothelial growth factor, often dysregulated
  • ADH/osmolality — antidiuretic hormone abnormalities causing dehydration and thirst

An HLA-DR gene test can identify whether a patient carries the susceptible genotype, helping confirm a CIRS diagnosis and guiding treatment expectations[3].

It is important to note that no single test is definitive for mold illness or environmental toxicity. The functional medicine approach relies on pattern recognition — combining exposure history, symptom clustering, genetic susceptibility testing, and multiple biomarker abnormalities to build a clinical picture. A practitioner experienced in environmental medicine will look for the convergence of evidence rather than a single positive result.

How Your Body Detoxifies: Phase I and Phase II Liver Pathways

Understanding the body's built-in detoxification system is essential to grasping why some people get sick from toxin exposure while others do not. The liver is the primary organ of detoxification, processing toxins through a sequential two-phase system[7].

Phase I: Activation (Cytochrome P450 System)

Phase I reactions, mediated primarily by the cytochrome P450 enzyme superfamily, modify lipophilic (fat-soluble) toxins by adding hydrophilic functional groups — essentially making them more water-soluble for further processing. However, this step often generates reactive intermediates that are more toxic than the original compound. If Phase II cannot keep pace with Phase I output, these intermediates accumulate and cause oxidative damage.

Phase II: Conjugation

Phase II enzymes attach molecules to the activated toxins to render them water-soluble and ready for excretion through bile or urine. The six major Phase II pathways are:

  • Glutathione conjugation — the most important pathway for mycotoxins and heavy metals
  • Glucuronidation — processes hormones, bilirubin, and many drugs
  • Sulfation — handles phenols, hormones, and neurotransmitters
  • Methylation — dependent on B12, folate, and SAMe
  • Acetylation — processes amines and sulfonamides
  • Amino acid conjugation — uses glycine and taurine

Research has demonstrated that specific foods and nutrients can modulate these pathways — cruciferous vegetables upregulate glucuronidation, sulfur-containing foods support glutathione synthesis, and polyphenols from berries and turmeric modulate Phase I/II balance[7].

Glutathione: The Master Detoxifier

Glutathione (GSH) is the body's most abundant intracellular antioxidant and the primary molecule for conjugating and excreting both mycotoxins and heavy metals. It binds directly to mercury, lead, cadmium, and arsenic through its sulfhydryl group, facilitating their transport and elimination[6]. In the context of mercury toxicity specifically, glutathione and alpha-lipoic acid have been studied for both their antioxidant-protective and chelation-supportive roles[8].

Glutathione status is often depleted in patients with chronic toxin exposure — creating a vicious cycle where the body's ability to clear toxins diminishes precisely when detoxification demand is highest. Supporting glutathione levels through direct supplementation (liposomal glutathione or IV glutathione), its precursors (N-acetylcysteine, glycine, glutamine), and cofactors (selenium, B vitamins, vitamin C) is a cornerstone of functional medicine detox protocols.

Treatment and Recovery: The Functional Medicine Approach

Recovery from mold illness and environmental toxin exposure follows a specific sequence. Treating too aggressively or out of order can worsen symptoms by mobilizing toxins faster than the body can excrete them.

Step 1: Remove the Source

No treatment protocol will succeed if the patient is still being exposed. This means professional mold remediation, addressing water damage, and potentially replacing contaminated belongings. For heavy metals, this may involve safe removal of amalgam fillings by a biological dentist trained in the SMART (Safe Mercury Amalgam Removal Technique) protocol.

Step 2: Bind and Remove Toxins

Biotoxin binders are substances that attach to toxins in the GI tract, preventing enterohepatic recirculation (the recycling of toxins from gut back to liver). The most well-studied binders include[9]:

  • Cholestyramine (CSM) — a prescription bile acid sequestrant that is the most researched binder for CIRS. It binds mycotoxins in the small intestine and facilitates fecal excretion.
  • Activated charcoal — a broad-spectrum binder effective for many organic toxins
  • Bentonite clay — binds aflatoxins and certain mycotoxins
  • Chlorella — a green algae with demonstrated heavy metal binding capacity
  • Modified citrus pectin — shown to enhance urinary excretion of lead, mercury, and arsenic

Step 3: Support Detoxification Pathways

  • Glutathione support — liposomal glutathione, NAC, whey protein concentrate
  • Phase II cofactors — glycine, taurine, magnesium, B vitamins (especially methylated folate and B12)
  • Cruciferous vegetables — sulforaphane from broccoli sprouts upregulates Nrf2-dependent antioxidant and detoxification enzymes
  • Sauna therapy — induced sweating has been studied as a route for eliminating both heavy metals and fat-soluble toxins through the skin[9]

Step 4: Repair and Restore

After toxin burden is reduced, focus shifts to repairing damaged systems:

  • Gut restoration — probiotics, L-glutamine, and dietary protocols (e.g., low-mold diet) to repair intestinal permeability
  • Neurological support — omega-3 fatty acids, lion's mane mushroom, and phosphatidylcholine for cognitive recovery
  • Hormonal rebalancing — addressing suppressed MSH, VIP, and other neuroendocrine markers disrupted by CIRS
  • Immune modulation — VIP nasal spray and other immunomodulatory agents used in the Shoemaker Protocol for persistent cases[2]

Step 5: Monitor and Prevent

Recovery is not linear. Regular retesting of biomarkers (TGF-beta 1, C4a, VIP, MSH), repeat urinary mycotoxin panels, and environmental monitoring are essential to confirm progress and catch reexposure early.

The Shoemaker Protocol: Evidence and Outcomes

The Shoemaker Protocol remains the most comprehensively documented treatment approach for CIRS. A 2024 literature review found it was the only treatment with documented clinical efficacy across published studies on CIRS, described in 11 of 13 identified treatment articles[2]. The protocol follows a sequential, step-wise approach: source removal, cholestyramine binding, eradication of MARCoNS (antibiotic-resistant nasal staph), correction of antigliadin antibodies, normalization of MMP-9 and VEGF, correction of ADH/osmolality, correction of C3a and C4a, correction of TGF-beta 1, restoration of VIP, and finally verification of sustained biomarker normalization.

While the Shoemaker Protocol has its critics — particularly regarding the specificity of some biomarkers and the need for larger randomized controlled trials — it provides a structured framework that many functional medicine practitioners adapt and integrate into broader treatment plans. The key insight of the protocol is its sequential nature: attempting to restore VIP or modulate immune function while the patient is still exposed to mold, or before toxin binding has been initiated, predictably fails. Order of operations matters in environmental medicine.

Prevention: Reducing Your Toxic Burden

Prevention strategies focus on minimizing exposure while maximizing the body's capacity to detoxify:

  • Indoor air quality — use HEPA air purifiers, maintain humidity below 50%, fix water leaks within 24–48 hours, and test for mold with ERMI or HERTSMI-2 scoring
  • Water filtration — reverse osmosis or activated carbon systems to remove heavy metals and VOCs from drinking water
  • Diet — choose organic produce (especially the Dirty Dozen), minimize large predatory fish (tuna, swordfish), and reduce processed food consumption
  • Personal care and household products — switch to fragrance-free, phthalate-free, and paraben-free products
  • Nutritional support — maintain adequate glutathione precursors (NAC, glycine), selenium, zinc, and cruciferous vegetable intake to support ongoing detoxification capacity

When to Seek Help

If you suspect environmental toxin exposure is contributing to chronic symptoms, working with a practitioner trained in environmental or functional medicine is strongly recommended. The complexity of CIRS diagnostics, the nuances of provoked testing, and the risks of improper chelation or overly aggressive detoxification protocols all argue against a purely self-directed approach. Look for practitioners certified through the International Society for Environmentally Acquired Illness (ISEAI) or those trained in the Shoemaker Protocol.

Environmental illness is real, measurable, and treatable — but it requires a systematic, evidence-informed approach. The science is advancing rapidly, and patients who were once dismissed as having psychosomatic complaints now have access to validated biomarkers, genetic testing, and structured treatment protocols that can fundamentally change their trajectory.

Frequently Asked Questions

What is CIRS (Chronic Inflammatory Response Syndrome)?

CIRS is a multi-system inflammatory illness caused by exposure to biotoxins — most often mycotoxins from water-damaged buildings. It occurs when genetically susceptible individuals (approximately 24% of the population with specific HLA-DR gene variations) cannot properly clear inhaled biotoxins, leading to persistent innate immune activation. Symptoms include fatigue, cognitive dysfunction, joint pain, respiratory issues, light sensitivity, and mood disturbances. CIRS is diagnosed through a combination of exposure history, symptom clustering, and specific biomarker abnormalities (TGF-beta 1, C4a, MMP-9, MSH, VIP). It is frequently misdiagnosed as fibromyalgia, chronic fatigue syndrome, or depression.

How do you test for mold exposure and mycotoxins?

Mycotoxin exposure is tested through urinary mycotoxin panels (such as RealTime Laboratories or GPL-MycoTOX) that detect specific mycotoxins like ochratoxin A, aflatoxins, gliotoxin, and trichothecenes. A provocative glutathione challenge before collection may improve test sensitivity by mobilizing stored toxins. Environmental testing via ERMI (Environmental Relative Moldiness Index) uses dust samples to quantify mold DNA in your home or workplace. For CIRS specifically, blood biomarkers including TGF-beta 1, C4a, MMP-9, MSH, and VIP help confirm diagnosis, while HLA-DR genetic testing identifies susceptibility.

Can mercury from dental amalgam fillings affect health?

Dental amalgam fillings are approximately 50% mercury by weight and continuously release low levels of mercury vapor. Research published in Neurotoxicology indicates that amalgam-derived mercury vapor is the predominant source of mercury in the central nervous system of adults in developed countries. Subclinical effects on kidneys, the immune system, thyroid function, and CNS function have been observed at exposure levels within the upper range seen in amalgam bearers. Individual susceptibility varies based on genetic polymorphisms affecting mercury metabolism. Safe removal should be performed by a biological dentist using the SMART protocol to minimize vapor exposure during the procedure.

What is glutathione, and why is it important for detoxification?

Glutathione (GSH) is the body's most abundant intracellular antioxidant and the primary molecule for conjugating and excreting both mycotoxins and heavy metals. Its sulfhydryl group binds directly to mercury, lead, cadmium, and arsenic, facilitating their transport and elimination from the body. Glutathione is also central to Phase II liver detoxification. In chronically exposed individuals, glutathione is often depleted — impairing the very system needed to clear toxins. Functional medicine supports glutathione through liposomal or IV supplementation, precursors like N-acetylcysteine (NAC), glycine, and glutamine, and cofactors including selenium, B vitamins, and vitamin C.

What are biotoxin binders, and how do they work?

Biotoxin binders are substances taken orally that attach to toxins in the gastrointestinal tract and prevent them from being reabsorbed into the bloodstream through enterohepatic recirculation. The most studied binder for mold illness is cholestyramine (CSM), a prescription bile acid sequestrant. Other commonly used binders include activated charcoal, bentonite clay, chlorella, and modified citrus pectin. Binders should be taken away from food and supplements (typically 30–60 minutes before or 2 hours after meals) to avoid interfering with nutrient absorption. They are most effective as part of a sequential treatment protocol that also addresses source removal and detoxification pathway support.

How long does recovery from mold illness or heavy metal toxicity take?

Recovery timelines vary significantly based on the severity and duration of exposure, genetic susceptibility (HLA-DR status), total toxin burden, and the individual's baseline health and detoxification capacity. For mold illness with full adherence to a treatment protocol, many patients experience noticeable improvement within 2–4 months, with significant recovery over 6–12 months. Complex cases with multiple toxin exposures, genetic susceptibility, and damaged detoxification pathways may require 12–24 months or longer. In HLA-DR-susceptible individuals, mycotoxin elimination can be extremely slow — ochratoxin A half-life has been measured at over 300 days in these individuals. Ongoing monitoring and prevention of reexposure are essential throughout recovery.

Explore Mold and Toxins Articles

Deep dives into specific topics within mold and toxins